Guidelines and critical pathways for severe hospital-acquired pneumonia

Chest

Volumn 119, Issue 2 SUPPL., 2001, Pages 412S-418S

  Fiel, S ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

American Thoracic Society guidelines; Antibiotic resistance; Antibiotics; Empiric therapy; Hospital acquired pneumonia; Nosocomial pneumonia; Patient quality of care

Indexed keywords

BETA LACTAMASE INHIBITOR; CEFEPIME; MEROPENEM; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; HEALTH CARE QUALITY; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPETENCE; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SURVIVAL;

EID: 0035110287     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.2_suppl.412S     Document Type: Article

References (24)

1. Hospital-acquired pnuemonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies
2. Association of aminoglycoside plasma levels with therapeutic outcome in Gram-negative pneumonia
3. Nosocomial pneumonia: A multivariate analysis of risk and prognosis
4. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
5. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
6. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes
7. A computer-assisted management program for antibiotics and other antiinfective agents
8. Detection of nosocomial lung infection in ventilated patients: Use of a protected specimen brush and quantitative culture techniques in 147 patients
9. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia
10. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
11. Antimicrobial-drug resistance
12. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection: Piperacillin/tazobactam Nosocomial Pneumonia Study Group
13. High-level aminoglycoside-resistant enterococci
14. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes
15. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries
16. Survey of blood-stream infections due to Gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
17. Bacteriology of hospital-acquired pneumonia
18. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures
19. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients
20. Risk factors for nosocomial Legionella pneumophila pneumonia
21. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
22. Gram-negative colonization of the respiratory tract: Pathogenesis and clinical consequences
23. Nosocomial pneumonia in patients receiving continuous mechanical ventilation
24. Ventilator-associated pneumonia by Staphylococcus aureus: Comparison of methicillin-resistant and methicillin-sensitive episodes